NEW YORK, May 16, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: <\/p>\n
Global Human Vaccines Industry <\/p>\n
http:\/\/www.reportlinker.com\/p092575\/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_<\/a> <\/p>\n This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report also analyzes the world market for Therapeutic Vaccines for the period 2010 to 2015. The report profiles 162 companies including many key and niche players such as ALK - Abello A\/S, Bavarian Nordic A\/S, Crucell N.V., CSL Ltd., GlaxoSmithKline PLC, GlaxoSmithKline Biologicals S.A, Medimmune, Inc., Merck & Company, Inc., Novartis Vaccines & Diagnostics, Inc., Sanofi, Sanofi-Pasteur SA, Sanofi Pasteur, Inc., Shanta Biotechnics Ltd., Vaxin, Inc., and Wyeth. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. <\/p>\n I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONSStudy Reliability and Reporting Limitations I-1Disclaimers I-2Data Interpretation & Reporting Level I-3Quantitative Techniques & Analytics I-3Product Definitions and Scope of Study I-3Prophylactic Vaccines I-3Therapeutic Vaccines I-4 <\/p>\n II. EXECUTIVE SUMMARY <\/p>\n 1. MARKET OVERVIEW & OUTLOOK II-1Human Vaccines Market Remains Resilient to Recession II-1Global Human Vaccines Market: A Snapshot II-1Market Dynamics II-2Vaccine Pricing: The Developed - Developing Divide II-2Growth Drivers in a Capsule II-3Developed World: The Key Markets II-3Looking Ahead II-3Emerging Markets: The Future Growth Area II-4Competitive Scenario II-5World's Leading Producers II-5Table 1: Leading Players in the Worldwide Vaccines Market(2008): Market Share Breakdown by Value Sales forGlaxoSmithKline, Sanofi-Aventis, Merck & Co., Novartis,Wyeth, and Others (includes corresponding Graph\/Chart) II-6ALK- The Global Leader in Allergy Vaccines II-6Table 2: Leading Players in the Worldwide Allergy VaccinesMarket (2005 & 2006 - A Historic Perspective): Market ShareBreakdown of Value Sales (*) for ALK- Abello, Stallergenes,Allergopharma, and Others (includes correspondingGraph\/Chart) II-7 <\/p>\n 2. PRODUCT OVERVIEW II-8 <\/p>\n Introduction to the Concept of Immunity II-8 <\/p>\n Role of Vaccines in Strengthening the Immune System II-8 <\/p>\n<\/p>\n The rest is here:<\/p>\n Global Human Vaccines Industry<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" NEW YORK, May 16, 2012 \/PRNewswire\/ --Reportlinker.com announces that a new market research report is available in its catalogue: Global Human Vaccines Industry http:\/\/www.reportlinker.com\/p092575\/Global-Human-Vaccines-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_<\/a> This report analyzes the worldwide markets for Prophylatic Human Vaccines in US$ Million by the following Product Segments: Pediatric Prophylactic Vaccines and Adult Prophylactic Vaccines. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. Annual estimates and forecasts are provided for the period 2009 through 2017. Continue reading